Agent summary statement for human immunodeficiency viruses (HIVs) including HTLV-III, LAV, HIV-1, and HIV-2

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Agent summary statement for human immunodeficiency viruses (HIVs) including HTLV-III, LAV, HIV-1, and HIV-2

April 1, 1988
By Centers for Disease Control (U.S.) ...
Source: MMWR. Morbidity and mortality weekly report. 1988; 37 Suppl 4:1-17.

[HTM]

Select to view the document on External site.

This document file type cannot be previewed

English

Details Related Documents You May Also Like

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report
Corporate Authors:

Centers for Disease Control (U.S.) ; National Institutes of Health (U.S.)

Centers for Disease Control (U.S.) ; National Institutes of Health (U.S.) Less -
Description:

In 1984, the Centers for Disease Control (CDC) and the National Institutes of Health (NIH), in consultation with experts from academic institutions, industry, and government, published the book Biosafety in Microbiological and Biomedical Laboratories ("Guidelines") [Richardson JH, Barkley WE, eds. Biosafety in microbiological and biomedical laboratories, 1984. Washington, DC: Public Health Service, 1984; DHHS publication no. (CDC)84-8395.].

These Guidelines are based on combinations of standard and special practices, equipment, and facilities recommended for use in working with infectious agents in various laboratory settings. The recommendations are advisory; they provide a general code for operating microbiologic and biomedical laboratories.

One section of the Guidelines is devoted to standard and special microbiologic practices, safety equipment, and facilities for biosafety levels (BSL) 1 through 4. Another section contains specific agent summary statements, each consisting of a brief description of laboratory-associated infections, the nature of laboratory hazards, and recommended precautions for working with the causative agent. The authors realized that the discovery of the availability of information about these agents would necessitate updating the agent summary. Such a statement for human immunodeficiency virus (HIV) (called HTLV-III/LAV when the Guidelines were published) was published in MMWR in 1986 [CDC. Human T-lymphotropic virus type III/lymphadenopathy-associated virus agent summary statement. MMWR 1986;35:540-2, 547-9]. The HIV agent summary statement printed in this Supplement updates the 1986 statement.
Subjects:

[+]

Acquired Immunodeficiency Syndrome Animals Animals, Laboratory Containment Of Biohazards Disinfection Equipment Contamination HIV Humans Protective Clothing Specimen Handling Waste Products
Source:

MMWR. Morbidity and mortality weekly report. 1988; 37 Suppl 4:1-17.
Pubmed ID:

2832719
Document Type:

Journal Issue
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
File Type:

No Additional Files

More +

Agent summary statement for human immunodeficiency viruses (HIVs) including HTLV-III, LAV, HIV-1, and HIV-2

Details:

Supporting Files

Related Documents

You May Also Like